Elevation Oncology Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Selling, General & Admin	14.9	15.83	8.45	1.8	0.54
Research & Development	25.43	78.72	23.6	15.48	5.34
Other Operating Expenses	5.11	0	0	0	0
Operating Expenses	45.45	94.55	32.05	17.28	5.88
Operating Income	-45.45	-94.55	-32.05	-17.28	-5.88
Other Expense / Income	0.23	0.51	-0.01	-0.01	-
Pretax Income	-45.67	-95.06	-32.04	-17.27	-5.88
Income Tax	0.03	0.03	0	0	0
Net Income	-45.7	-95.08	-32.04	-17.27	-5.88
Shares Outstanding (Basic)	34	23	12	1	1
Shares Outstanding (Diluted)	34	23	12	1	1
Shares Change	46.46%	91.77%	1432.24%	6.43%	-
EPS (Basic)	-1.34	-4.09	-2.64	-21.80	-7.91
EPS (Diluted)	-1.34	-4.09	-2.64	-21.80	-7.91
Free Cash Flow	-56.18	-85.57	-30.17	-12.37	-5.45
Free Cash Flow Per Share	-1.65	-3.68	-2.49	-15.62	-7.33
EBITDA	-45.64	-95.03	-32.02	-17.25	-5.88
Depreciation & Amortization	0.04	0.03	0.02	0.02	0
EBIT	-45.67	-95.06	-32.04	-17.27	-5.88

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).